In this study, we have implemented a genomewide approach to describe for the first time the mechanisms of basal and retinoid-repressed OTX2 transcription in medulloblastoma, thus contributing to the understanding of critical events in both medulloblastoma tumorigenesis and its response to differentiation therapy. The gene discussed is OTX2; the disease is medulloblastoma.